India’s Cosmetic Revolution: Navigating Growth and Regulatory Transformations
No Thumbnail Available
Date
2026-06-13
Journal Title
Journal ISSN
Volume Title
Publisher
Chitkara University Publications
Abstract
Background: The Indian cosmetic industry has witnessed rapid expansion due to urbanization, rising disposable incomes, and increasing demand for natural and cruelty-free products. This growth has driven the need for a well-defined regulatory framework. The Drugs and Cosmetics Act, 1940, along with oversight by the Central Drugs Standard Control Organization (CDSCO) and standards set by the Bureau of Indian Standards (BIS), forms the foundation of cosmetic regulation in India. The introduction of the Cosmetics Rules, 2020 has further strengthened the regulatory system by modernizing definitions, licensing procedures, and safety requirements.
Purpose: This review aims to critically analyze the current regulatory framework governing the design, manufacturing, and distribution of cosmetics in India, with emphasis on recent amendments and their practical implications.
Methods: A qualitative narrative review was conducted using secondary data sources, including regulatory documents, CDSCO guidelines, BIS standards, and relevant literature retrieved from PubMed, Scopus, and Google Scholar (2010–2025). Only studies relevant to cosmetic regulation were included.
Results: The review identifies that the Cosmetics Rules, 2020 have significantly streamlined licensing procedures, introduced risk-based regulatory oversight, and improved alignment with international frameworks, particularly in areas of GMP compliance, labeling requirements, and import regulation.
Conclusion: The updated regulatory framework has enhanced transparency, product safety, and quality assurance within the Indian cosmetic sector. Further alignment with global standards and supportive measures for industry stakeholders can strengthen regulatory effectiveness and promote sustainable growth.
Description
Keywords
Bureau of Indian Standards, Cosmetic rules 2020, Drugs and Cosmetics Act, Import, Labeling